SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is currently a major focus for investors as the community analyzes the BLA submission for its ivonescimab platform, with active discussions centered on the upcoming FDA PDUFA date and the potential for the drug to challenge current standards in oncology. Market sentiment is heavily divided between conviction in the drug's clinical data and competitive trial results against existing blockbusters, leading to significant volatility as traders weigh the risks of further capital raises against the potential for a paradigm shift in lung cancer treatment.

This has been pretty requested, so here's a short explainer of what $Staccana is:  @STACCoverflow has cooked up a Solana fork using some tech that was created, but never utilized since Solana cannot rollback or change inherent promises the chain makes. Here are the promises that Staccana chain makes:  a. Token transfers are encrypted by default b. Launches use frequent-batch auctions (MEV is not possible on this chain)  I've been coordinating with Stacc to help create a flywheel for this meme coin and the native ssSOL token. If you want early access to the chain, best rewards, and to become a part of this ecosystem you want to be invested in $Staccana.  Said flywheel is being cooked by Stacc as we speak, and the plan is to release Staccana main net on May 16th. I will be contributing the locked 4.6% supply to LPs for the flywheel.  Creator fees will be used to bootstrap the network, incentivize early users, and to add to the Stacanna treasury.  73edX6xoGY4v5y2hzuKdrUbJXLntqgmo74au1Ki1pump

Solana Fork Staccana

The community is buzzing around the upcoming mainnet launch for this Solana fork, focusing on its integration of privacy features and liquid staking utility. While proponents highlight early-stage growth potential and team pedigree, skeptics remain vocal regarding the project's legitimacy and development roadmap.

Doodles is a next-generation entertainment company focused on immersive storytelling through the creation and distribution of live and digital experiences, original content, and lifestyle products.  Doodles mission is to define the standard for immersive storytelling and color the world with joy.

Doodle Inu

Doodle Inu is attracting attention as community members debate its potential for a sustained run, frequently comparing its outlook to other trending meme coins and highlighting the utility of its integrated AI-powered creative app. While some traders are actively accumulating positions in anticipation of a breakout, others remain cautious, voicing concerns about high volatility and the influence of automated trading bots on price action.

Unleash Jugs

JUGS is gaining community attention as a new meme-focused cryptocurrency, with participants speculating on potential price appreciation and the impact of concentrated ownership among top holders. Discussions are highly speculative, centered on the token's early launch phase and aggressive momentum-based optimism.

Agnico Eagle Mines Ltd. engages in the exploration and production of gold. It operates through the following segments: Northern Business, Southern Business, and Exploration. The Northern Business segment comprises of LaRonde mine, LaRonde Zone 5 mine, Lapa mine, Goldex mine, Meadowbank mine including the Amaruq deposit, Canadian Malartic joint operation, Meliadine project and Kittila mine. The Southern Business segment consists of Pinos Altos mine, Creston Mascota mine, and La India mine. The Exploration segment represents the exploration offices in the United States, Europe, Canada, and Latin America. The company was founded by Paul Penna in 1957 and is headquartered in Toronto, Canada.

Agnico Eagle Mines Ltd

Agnico Eagle Mines is currently trending as a top-tier gold miner, with the community highlighting its record-breaking cash flow, consistent earnings beats, and significant debt reduction. Investors are actively discussing the stock's growth potential fueled by rising gold prices, strategic project investments, and its status as a reliable hedge against market volatility.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is trending as investors debate its long-term viability, with the community polarized between those betting on Real World Asset tokenization and others expecting further downside. Discussion is heavily focused on the coin's historical price performance and a mix of skepticism and speculative optimism regarding potential bull cycles.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is experiencing significant volatility following reports that buyout talks with Merck have collapsed due to valuation disagreements, cooling near-term acquisition expectations. Despite this setback, the broader community remains focused on the company's robust RAS(ON) inhibitor pipeline and upcoming clinical data catalysts as long-term drivers of value.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is facing heightened community anxiety as it drifts near multi-year lows, leaving investors divided between those capitulating at a loss and those accumulating in anticipation of a rebound driven by institutional RWA tokenization. While long-term bulls point to its recent ETF launch and infrastructure adoption as catalysts for a recovery, many traders are vocal about their frustration with the token's persistent lag behind Bitcoin and broader market weakness.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen is trending as investors react to its recent deal with the Trump administration to lower U.S. drug prices while expanding domestic manufacturing efforts. The community is actively discussing the company's long-term growth prospects alongside its pipeline updates and overall positioning within the broader pharmaceutical sector.

Constellation Software, Inc. is a holding company, which acquires, manages and builds vertical market software businesses. The company was founded by Mark Henri Leonard and James D. Foy on August 23, 1995 and is headquartered in Toronto, Canada.

Constellation Software Inc

Constellation Software is trending as investors weigh its robust free cash flow and proven acquisition-driven growth against concerns regarding potential AI-driven disruption to the vertical market software sector. The community is actively debating whether the stock's recent volatility represents a compelling generational buying opportunity or a warning sign as the company continues to aggressively deploy capital.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lifecore Biomedical (NASDAQ:LFCR) Posts Quarterly Earnings Results, Misses Expectations By $0.19 EPS

Lifecore Biomedical (NASDAQ:LFCR - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.43) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by ($0.19). Lifecore Biomedical had a negative return on equity of 1,211.09% and a negative net margin of...

Lifecore Biomedical Q1 Earnings Call Highlights

Lifecore Biomedical (NASDAQ:LFCR) executives highlighted new commercial site transfer wins, continued cost reductions, and improving liquidity during the company's first-quarter 2026 earnings call...

Lifecore Biomedical Q1 2026 Earnings Call Transcript

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Given Average Recommendation of "Hold" by Brokerages

Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) has been assigned a consensus recommendation of 'Hold' from the five brokerages that are currently covering the company, Marketbeat.com...

Lifecore Biomedical (NASDAQ:LFCR) Price Target Raised to $6.00

Barrington Research upped their target price on Lifecore Biomedical from $5.50 to $6.00 and gave the stock an "outperform" rating in a research note on Wednesday...

Lifecore Biomedical (LFCR) to Release Earnings on Tuesday

Lifecore Biomedical (NASDAQ:LFCR) will be releasing earnings after the market closes on Tuesday, May 5. (View Earnings Report at...

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Receives Average Recommendation of "Hold" from Analysts

Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) have received a consensus recommendation of "Hold" from the five brokerages that are covering the firm, MarketBeat reports. One...

Lifecore Biomedical (LFCR) to Release Earnings on Thursday

Lifecore Biomedical (NASDAQ:LFCR) will be releasing earnings after the market closes on Thursday, April 2. (View Earnings Report at...

Lifecore Biomedical (NASDAQ:LFCR) Earns Outperform Rating from Barrington Research

Barrington Research reiterated an "outperform" rating and issued a $5.50 price target on shares of Lifecore Biomedical in a research report on Tuesday...

Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029

Lifecore Biomedical (NASDAQ:LFCR) CEO Paul Josephs told investors at a KeyBanc conference that the company has completed its transition into a standalone CDMO after divesting its former food...

Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.

Current Price	$5.02
Prev Close	$4.97
Open	$4.96
Dividend Yield	0.00%
50-Day Moving Average	$4.65
Beta	1.47
Avg. Volume	323,503.89
PE Ratio	-3.85

52-Week High	$8.98
52-Week Low	$3.63
Market Capitalization	$188.3M
EPS (Annual)	-$1.27
Price to Book	-6.62
Revenue Per Employee	$317,406.40

LFCR
Lifecore Biomedical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest LFCR News

LFCRLifecore Biomedical Inc